Related Experiment Video

Updated: Mar 9, 2026

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
09:24

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

4.8K

SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization

Nkerorema Djodji Damas1, Michela Marcatti1, Christophe Côme1

  • 1Biotech Research and Innovation Centre, University of Copenhagen, Ole Maaloes Vej 5 2200 Copenhagen, Denmark.

Nature Communications
|December 23, 2016
PubMed

Insights

This study identifies SNHG5, a long non-coding RNA (lncRNA), as crucial for colorectal cancer survival. SNHG5 protects cancer cells by stabilizing target transcripts and inhibiting apoptosis, offering new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Biology

Background:

  • Limited understanding of long non-coding RNAs (lncRNAs) in cellular processes and diseases.
  • Colorectal cancer (CRC) pathogenesis involves complex molecular mechanisms.
  • Identifying novel regulatory molecules in cancer is critical for therapeutic development.

Purpose of the Study:

  • To identify and characterize the role of SNHG5, a novel lncRNA, in colorectal cancer.
  • To elucidate the molecular mechanism by which SNHG5 influences cancer cell survival and treatment response.
  • To explore SNHG5 as a potential therapeutic target in colorectal cancer.

Main Methods:

  • Identification and characterization of SNHG5 expression in colorectal cancer.
  • In vitro and in vivo functional assays (cell cycle arrest, apoptosis, tumor outgrowth).
  • RNA-immunoprecipitation (RIP) and transcriptomic analysis to identify SNHG5 interacting partners.
  • Knockdown and overexpression studies of SNHG5, SPATS2, and STAU1.

Main Results:

  • SNHG5 is upregulated in colorectal cancer and promotes tumor cell survival.
  • SNHG5 depletion induces cell cycle arrest and apoptosis, while its overexpression confers resistance to oxaliplatin.
  • SNHG5 stabilizes target transcripts, including SPATS2, by inhibiting STAU1-mediated degradation, thereby promoting cancer cell survival.

Conclusions:

  • SNHG5 is a cytoplasmic lncRNA that enhances colorectal cancer cell survival.
  • SNHG5 functions by stabilizing target transcripts through the inhibition of STAU1.
  • SNHG5 represents a potential therapeutic target for colorectal cancer treatment.

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.3K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.1K

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K